Concepedia

Author

Brian R. Murphy

National Institutes of Health

Also Known As

Alexander C. Schmidt, Bhavin Thumar, Brian R. Murphy, Brian R. Murphy

12

Publications

1.2K

Citations

11

H-Index

10

Concepts

All Affiliations

National Institutes of HealthNational Institute of Allergy and Infectious DiseasesJohns Hopkins University
BR

About

Brian R. Murphy is an author at National Institutes of Health specializing in virology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

606

2

Immunology

6

6

606

3

Pathogenesis

2

2

209

4

Microbiology

1

1

69

5

Vaccine Development

1

1

34

Brian R. Murphy

×

9

Publications

1.1K

Citations

9

H-Index

YearCitations

Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

Ruth A. Karron, Peter F. Wright, Robert B. Belshe,

The Journal of Infectious Diseases

2005

283

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization

Brian R. Murphy, Alex V. Sotnikov, Lisa Lawrence,

Vaccine

1990

271

Measles Virus Infection in Rhesus Macaques: Altered Immune Responses and Comparison of the Virulence of Six Different Virus Strains

Paul G. Auwaerter, Paul A. Rota, William R. Elkins,

The Journal of Infectious Diseases

1999

138

rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

Anna P. Durbin, Stephen S. Whitehead, Julie H. McArthur,

The Journal of Infectious Diseases

2005

123

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys

Susan L. Hall, A. Stokes, E L Tierney,

Virus Research

1992

71

Expression of biologically active and antigenically authentic parainfluenza Type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus

Kathleen L. van Wyke Coelingh, Brian R. Murphy, Peter L. Collins,

Virology

1987

69

Comparison of the Immunogenicity and Efficacy of a Replication‐Defective Vaccinia Virus Expressing Antigens of Human Parainfluenza Virus Type 3 (HPIV3) with Those of a Live Attenuated HPIV3 Vaccine Candidate in Rhesus Monkeys Passively Immunized with PIV3 Antibodies

Anna P. Durbin, Chris J. Cho, William R. Elkins,

The Journal of Infectious Diseases

1999

41

Attenuation of the Recombinant Human Parainfluenza Virus Type 3 cp45 Candidate Vaccine Virus Is Augmented by Importation of the Respiratory Syncytial Virus cpts530 L Polymerase Mutation

Mario H. Skiadopoulos, Sonja R. Surman, Marisa St. Claire,

Virology

1999

34

Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization

Srikantan Vasantha, Kathleen Coelingh, Brian R. Murphy,

Virology

1988

23

Page 1